Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?

Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma:... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Haematologica Unpaywall

Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?

Loading next page...
 
/lp/unpaywall/mogamulizumab-versus-investigator-choice-in-relapsed-refractory-adult-AvcfrL4oHI

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0390-6078
DOI
10.3324/haematol.2018.214536
Publisher site
See Article on Publisher Site

Abstract

Journal

HaematologicaUnpaywall

Published: Apr 30, 2019

There are no references for this article.